Reuters -- Pfizer Inc (PFE.N) is set to make a near $4 billion offer for German generic drug maker Ratiopharm GmbH this week, competing with bids from Teva Pharmaceutical Industries Ltd (TEVA.TA) and Actavis, several sources familiar with the situation said.
